U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07071974) titled 'A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body' on July 16.

Brief Summary: The main objective of this trial is to investigate relative bioavailability of BI 456906 reference formulation (Formulation A) vs. BI 456906 test formulation (Formulation B2).

Study Start Date: July 28

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: BI 456906 formulation A

BI 456906 formulation A

DRUG: BI 456906 formulation B2

BI 456906 formulation B2

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Boehringer Ingelheim

Disclaimer: Curated by HT Syndication....